Group 1: New Energy Business - The company primarily focuses on the sales of LiFSI, cathode materials, and electrolyte products, with ongoing technical improvements on lithium hexafluorophosphate projects. Revenue from the new energy business is expected to break through in 2025, with further growth anticipated in 2026 [1] - The company aims to expand its product range and market presence in the new energy sector, leveraging its R&D and production capabilities to convert technological advantages into market benefits [1] - The new energy sector is viewed as a sufficiently broad and long-term opportunity, helping to mitigate operational risks associated with the company's previous focus on overseas CDMO clients [2] Group 2: Overseas Operations - The UK base has maintained stable production and operations in 2025, with expectations for continued stability in 2026. The Malaysian base plans to invest $200 million, with the first phase of construction ongoing and expected to complete by the end of 2026 [3] - The Malaysian facility will focus on producing agricultural CDMO products, with plans to gradually commence production based on customer orders starting in 2027 [3] Group 3: Pharmaceutical Business - The pharmaceutical segment has shown steady growth, with a focus on a large client strategy and CDMO business model. The company has established stable commercial relationships with several leading global pharmaceutical companies [4] - The company is actively expanding its client base and developing new strategic partnerships, particularly with high-viscosity clients, while also focusing on small molecule CDMO and emerging business areas such as peptide products and radiopharmaceuticals [4] Group 4: Client Dependency and Market Strategy - The company acknowledges a high concentration of clients but emphasizes the importance of providing comprehensive services to existing clients while actively seeking new customers across various sectors [4] - The strategy includes enhancing technical capabilities and market expansion to foster long-term cooperation and mutual trust with clients, ensuring a sustainable business model [4]

事件: 2025 年4 月19 日，公司发布一季报：2025Q1 单季度，公司实现营业收入3.44 亿元，同比+4.83%，环 比-5.83%；实现归母净利润为0.46 亿元，同比+32.90%，环比-31.30%；扣非后归母净利润0.42亿元，同 比+32.48%，环比-33.82%；销售毛利率为42.48%，同比+6.28 个pct，环比-4.40 个pct；销售净利率为 13.27%，同比+2.81个pct，环比-4.91 个pct；2025 年Q1 季度末，公司存货金额为4.84亿元，同比 +1.43%，环比-0.19%；2025Q1 单季度公司经营活动产生的现金流净额为0.31 亿元，同比-21.95%，环 比-69.40%。 投资要点: 下游终端消费电子需求回暖，2024 年归母净利润同比大幅提升2024 年公司实现营业收入14.59 亿元，同 比增长20.74%；归属于上市公司股东的净利润2.52 亿元，同比增长87.60%，扣非后净利润2.37 亿元， 同比增长103.43%；经营活动产生的现金流量净额4.19 亿元，同比减少6.79%。分业务板块看，显示材 料板块实现销售收入12.76 亿元 ...